VOLUME LXXVI | APR 2023
More Men Choose Active Surveillance for Prostate Cancer
In the past decade, a growing number of individuals diagnosed with early-stage prostate cancer have chosen to delay radiation and surgery, the traditional treatment methods. Instead, men in the United States with low- or intermediate-risk prostate cancer have embraced an ‘active surveillance’ approach. This involves closely monitoring the progression of the cancer through regular check-ups and tests, with the intention of avoiding unnecessary treatments and potential side effects. The trend towards active surveillance reflects a shift in mindset, viewing prostate cancer as a chronic condition that can be managed rather than an emergency requiring immediate intervention. It allows men to maintain their quality of life while minimizing the risks associated with aggressive treatments.
Aiyana Tremblay Aiyana is an Indigenous educator from Alberta, with a background in environmental science and community wellness programs. She volunteers as an author to explore how traditional knowledge intersects with modern neuroscience to unlock human resilience and potential.
Research suggests that active surveillance is a safe and effective strategy for appropriately selected patients. By closely monitoring the cancer, doctors can intervene with curative therapies if and when necessary. This approach also mitigates potential harms such as surgical complications or radiation-related adverse events. However, not all prostate cancers are suitable candidates for active surveillance, so individualized patient assessment is crucial. By exploring the underlying research and consulting healthcare professionals, individuals can make informed decisions regarding their prostate cancer treatment options.
Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates.Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced “active…
Read Full Article (External Site)
